| abstract |
The invention provides a 5-D-fructose dehydrogenase, optionally in combination with invertase and/or maltase and/or glucose isomerase, for use in medicine, preferably in the form of a pharmaceutical composition. More particularly, the invention provides a 5-D-fructose dehydrogenase, optionally in combination with invertase and/or maltase and/or glucose isomerase, for use in the therapy of fructose intolerance. |